Gatifloxacin

CAS No. 112811-59-3

Gatifloxacin ( AM 1155;BMS 206584-01;PD 135432;AM1155;BMS206584-01 )

Catalog No. M10449 CAS No. 112811-59-3

A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 37 In Stock
1G 43 In Stock

Biological Information

  • Product Name
    Gatifloxacin
  • Note
    Research use only, not for human use.
  • Brief Description
    A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV.
  • Description
    A fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV; displays 2- to 16-fold more active than ciprofloxacin and ofloxacin against Staphylococcus aureus with MICs of 0.1-0.78 ug/mL.
  • Synonyms
    AM 1155;BMS 206584-01;PD 135432;AM1155;BMS206584-01
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    TopoIV
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    112811-59-3
  • Formula Weight
    375.39
  • Molecular Formula
    C19H22FN3O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    COC1=C2N(C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNC(C)C1)C1CC1
  • Chemical Name
    3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Hosaka M, et al. Antimicrob Agents Chemother. 1992 Oct;36(10):2108-17.
2. Tomioka H, et al. Antimicrob Agents Chemother. 1993 Jun;37(6):1259-63.
3. Wakabayashi E, et al. Antimicrob Agents Chemother. 1994 Mar;38(3):594-601.
molnova catalog
related products
  • Sulbenicillin Sodium

    Sulbenicillin Sodium is is a penicillin antibioticis a Penicillin antibiotic with antibacterial activity.

  • Linaroside

    Linaroside exhibited 30% inhibition for antimycobacterial activity against Mycobacterium tuberculosis, strain H(37)Rv at 6.25 microg mL(-1) concentration.

  • PBP 10

    Selective formyl peptide receptor 2 (FPR2) antagonist; cell permeable. Selectively inhibits FPR2-mediated NADPH oxidase activity but has no effect on FPR1 signaling in neutrophils. Displays PIP2 binding activity in vitro and blocks cell motility. Also exhibits antiviral activity against influenza viruses via inhibition of viral-induced ERK activation.